Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for PRAX

Stock Name	Praxis Precision Medicines Inc
Ticker	PRAX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US74006W1080

Show aggregate PRAX holdings

News associated with PRAX

Praxis Precision Medicines (NASDAQ:PRAX) Raised to “Strong-Buy” at Lifesci Capital: Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) was upgraded by equities research analysts at Lifesci Capital to a “strong-buy” rating in a report issued on Wednesday,Zacks.com reports. PRAX has been the subject of a number of other research reports. HC Wainwright reissued a “buy” rating and issued a $115.00 price objective (up previously from […] - 2025-09-05 05:03:08
Brokerages Set Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Price Target at $85.88: Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation and seven have given a buy recommendation to the company. The average twelve-month target […] - 2025-08-20 02:55:14
Notable Thursday Option Activity: ADBE, SOC, PRAX: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Adobe Inc (Symbol: ADBE), where a total of 32,666 contracts have traded so far, representing approximately 3.3 million underlying shares. That amounts to about 74.3% of - 2025-07-17 16:34:10
Praxis Precision Medicines (NASDAQ:PRAX) Shares Up 10.4% Following Analyst Upgrade: Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report)’s share price rose 10.4% during trading on Wednesday after Oppenheimer raised their price target on the stock from $97.00 to $115.00. Oppenheimer currently has an outperform rating on the stock. Praxis Precision Medicines traded as high as $51.36 and last traded at $51.63. Approximately 285,956 shares […] - 2025-07-11 02:22:49
Brokerages Set Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Target Price at $109.90: Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation and eight have given a buy recommendation to the company. The average 1-year target price […] - 2025-07-01 03:06:54
Analysts Set Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Price Target at $109.90: Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) has received a consensus rating of “Moderate Buy” from the ten research firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation and nine have assigned a buy recommendation to the company. The average 12 month price […] - 2025-06-06 02:28:56
Squarepoint Ops LLC Reduces Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): Squarepoint Ops LLC decreased its holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 46.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,782 shares of the company’s stock after selling 6,876 shares during the quarter. Squarepoint Ops LLC’s […] - 2025-06-04 05:04:49
Oppenheimer Begins Coverage on Praxis Precision Medicines (NASDAQ:PRAX): Analysts at Oppenheimer started coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) in a research note issued on Monday, Marketbeat Ratings reports. The firm set an “outperform” rating and a $97.00 price target on the stock. Oppenheimer’s price objective would indicate a potential upside of 135.44% from the stock’s previous close. […] - 2025-06-04 02:42:45
Man Group plc Sells 1,209 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX): Man Group plc reduced its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 29.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,832 shares of the company’s stock after selling 1,209 shares during […] - 2025-05-28 05:36:51
ProShare Advisors LLC Makes New Investment in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): ProShare Advisors LLC purchased a new stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 5,738 shares of the company’s stock, valued at approximately $442,000. A number of other hedge funds also recently made changes to their positions in PRAX. Barclays PLC boosted its […] - 2025-05-28 04:54:52
D. E. Shaw & Co. Inc. Increases Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): D. E. Shaw & Co. Inc. lifted its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 3.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,993 shares of the company’s stock after acquiring an additional 1,629 shares […] - 2025-05-19 05:10:52
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $116.50 Average Target Price from Brokerages: Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating and nine have given a buy rating to the company. The average […] - 2025-05-12 02:39:03
Voya Investment Management LLC Trims Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): Voya Investment Management LLC lowered its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 7.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,228 shares of the company’s stock after selling 441 shares during the quarter. Voya […] - 2025-05-11 05:35:04
Needham & Company LLC Reiterates Buy Rating for Praxis Precision Medicines (NASDAQ:PRAX): Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Needham & Company LLC in a report released on Monday,Benzinga reports. They currently have a $80.00 target price on the stock. Needham & Company LLC’s target price would indicate a potential upside of 127.47% from the stock’s previous […] - 2025-05-07 02:58:50
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Purchased by Wells Fargo & Company MN: Wells Fargo & Company MN increased its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 46.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 8,612 shares of the company’s stock after acquiring an additional 2,746 shares during the quarter. Wells Fargo & Company MN’s holdings in Praxis Precision […] - 2025-05-02 04:22:58
Invesco Ltd. Has $6.69 Million Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): Invesco Ltd. cut its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 19.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 86,983 shares of the company’s stock after selling 20,730 shares during the quarter. Invesco Ltd. owned approximately 0.47% of […] - 2025-04-25 05:08:54
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Recommendation of “Moderate Buy” from Brokerages: Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the nine analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating on the company. The […] - 2025-04-14 02:10:53
Critical Comparison: Praxis Precision Medicines (NASDAQ:PRAX) versus Sycamore Entertainment Group (OTCMKTS:SEGI): Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) and Sycamore Entertainment Group (OTCMKTS:SEGI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk. Profitability This table compares Praxis […] - 2025-04-08 02:17:03
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Corebridge Financial Inc.: Corebridge Financial Inc. reduced its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 7.0% in the 4th quarter, Holdings Channel reports. The fund owned 8,574 shares of the company’s stock after selling 646 shares during the period. Corebridge Financial Inc.’s holdings in Praxis Precision Medicines were worth $660,000 at the end of […] - 2025-04-07 04:32:48
US Bancorp DE Lowers Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): US Bancorp DE reduced its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 57.7% during the 4th quarter, HoldingsChannel reports. The fund owned 968 shares of the company’s stock after selling 1,321 shares during the period. US Bancorp DE’s holdings in Praxis Precision Medicines were worth $74,000 at the end […] - 2025-03-18 05:13:01
Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year Low After Analyst Downgrade: Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) reached a new 52-week low during trading on Tuesday after Wedbush downgraded the stock from a hold rating to a strong sell rating. The stock traded as low as $30.01 and last traded at $32.63, with a volume of 94961 shares traded. The stock […] - 2025-03-06 05:08:14
New York State Common Retirement Fund Has $604,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX): New York State Common Retirement Fund raised its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 12.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 7,847 shares of the company’s stock after buying an additional 847 shares during the period. New York State […] - 2025-03-05 09:01:03
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Stock Holdings Decreased by Rhumbline Advisers: Rhumbline Advisers decreased its stake in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Free Report) by 1.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,769 shares of the company’s stock after selling 347 shares during the period. Rhumbline Advisers’ holdings in Praxis Precision […] - 2025-03-05 08:08:59
HC Wainwright Has Lowered Expectations for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price: Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price objective decreased by stock analysts at HC Wainwright from $120.00 to $105.00 in a report released on Monday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective would suggest a potential upside of 189.98% from the […] - 2025-03-05 05:04:58
Needham & Company LLC Lowers Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $85.00: Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) had its price target cut by investment analysts at Needham & Company LLC from $150.00 to $85.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s price objective indicates a […] - 2025-03-05 05:04:55
Truist Financial Cuts Praxis Precision Medicines (NASDAQ:PRAX) Price Target to $85.00: Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Truist Financial from $175.00 to $85.00 in a research note released on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other research analysts have also issued reports on PRAX. Needham & Company LLC cut their target […] - 2025-03-04 04:52:56
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives $145.20 Average Target Price from Brokerages: Praxis Precision Medicines, Inc. (NASDAQ:PRAX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the ten research firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month […] - 2025-02-26 04:23:00
Deutsche Bank Aktiengesellschaft Initiates Coverage on Praxis Precision Medicines (NASDAQ:PRAX): Deutsche Bank Aktiengesellschaft assumed coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research note issued to investors on Tuesday, MarketBeat Ratings reports. The brokerage issued a buy rating and a $111.00 price target on the stock. A number of other research firms have also commented on PRAX. Oppenheimer increased their […] - 2025-02-14 06:32:53

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) PRAX holdings

Date	Number of PRAX Shares Held	Base Market Value of PRAX Shares	Local Market Value of PRAX Shares	Change in PRAX Shares Held	Change in PRAX Base Value	Current Price per PRAX Share Held	Previous Price per PRAX Share Held
2025-11-11 (Tuesday)	13,668	USD 2,508,898	USD 2,508,898	0	USD 214,177	USD 183.56	USD 167.89
2025-11-10 (Monday)	13,668	USD 2,294,721	USD 2,294,721	35	USD 1,378	USD 167.89	USD 168.22
2025-11-07 (Friday)	13,633	USD 2,293,343	USD 2,293,343	0	USD -56,305	USD 168.22	USD 172.35
2025-11-06 (Thursday)	13,633	USD 2,349,648	USD 2,349,648	35	USD 110,873	USD 172.35	USD 164.64
2025-11-05 (Wednesday)	13,598	USD 2,238,775	USD 2,238,775	0	USD -96,682	USD 164.64	USD 171.75
2025-11-04 (Tuesday)	13,598	USD 2,335,457	USD 2,335,457	35	USD -132,873	USD 171.75	USD 181.99
2025-11-03 (Monday)	13,563	USD 2,468,330	USD 2,468,330	0	USD -227,452	USD 181.99	USD 198.76
2025-10-31 (Friday)	13,563	USD 2,695,782	USD 2,695,782	0	USD -30,381	USD 198.76	USD 201
2025-10-30 (Thursday)	13,563	USD 2,726,163	USD 2,726,163	175	USD 105,328	USD 201	USD 195.76
2025-10-29 (Wednesday)	13,388	USD 2,620,835	USD 2,620,835	70	USD -33,842	USD 195.76	USD 199.33
2025-10-28 (Tuesday)	13,318	USD 2,654,677	USD 2,654,677	0	USD 178,328	USD 199.33	USD 185.94
2025-10-27 (Monday)	13,318	USD 2,476,349	USD 2,476,349	0	USD 159,417	USD 185.94	USD 173.97

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of PRAX by Blackrock for IE00BDZVHG35

Show aggregate share trades of PRAX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 35 174.990 160.375 161.837 USD 5,664 62.07
2025-11-06 BUY 35 175.960 160.900 162.406 USD 5,684 60.64
2025-11-04 BUY 35 186.600 171.740 173.226 USD 6,063 59.21
2025-10-30 BUY 175 206.360 191.390 192.887 USD 33,755 56.46
2025-10-29 BUY 70 195.760 198.290 198.037 USD 13,863 55.51
2025-10-22 SELL -140 184.430 192.960 192.107 USD -26,895 50.94 Loss of -19,764 on sale
2025-10-20 BUY 70 175.070 190.270 188.750 USD 13,213 49.04
2025-10-17 BUY 175 189.990 203.575 202.216 USD 35,388 48.02
2025-10-15 BUY 280 57.350 57.630 57.602 USD 16,129 47.95
2025-10-03 BUY 245 54.380 55.860 55.712 USD 13,649 47.87
2025-10-02 BUY 35 55.190 55.195 55.194 USD 1,932 47.82
2025-09-30 BUY 70 53.000 55.330 55.097 USD 3,857 47.74
2025-09-26 BUY 70 52.440 53.725 53.596 USD 3,752 47.67
2025-09-25 BUY 70 49.250 50.560 50.429 USD 3,530 47.65
2025-09-18 BUY 35 45.230 47.980 47.705 USD 1,670 47.67
2025-09-17 BUY 105 44.030 46.050 45.848 USD 4,814 47.70
2025-09-11 SELL -35 39.420 40.690 40.563 USD -1,420 47.81 Profit of 254 on sale
2025-09-10 BUY 70 40.230 40.610 40.572 USD 2,840 47.88
2025-07-17 SELL -70 54.940 58.340 58.000 USD -4,060 47.77 Loss of -716 on sale
2025-07-11 SELL -280 50.540 51.380 51.296 USD -14,363 47.61 Loss of -1,032 on sale
2025-07-02 BUY 1,925 46.320 46.600 46.572 USD 89,651 47.58
2025-06-25 BUY 70 43.330 44.100 44.023 USD 3,082 47.74
2025-06-20 BUY 609 42.340 43.270 43.177 USD 26,295 47.89
2025-06-11 BUY 66 44.595 46.930 46.697 USD 3,082 48.18
2025-06-10 BUY 66 45.850 46.090 46.066 USD 3,040 48.20
2025-06-04 SELL -33 41.370 42.665 42.536 USD -1,404 48.42 Profit of 194 on sale
2025-04-23 BUY 33 36.590 37.970 37.832 USD 1,248 53.49
2025-04-10 SELL -264 28.470 30.175 30.004 USD -7,921 57.10 Profit of 7,153 on sale
2025-04-08 SELL -33 28.600 33.990 33.451 USD -1,104 58.15 Profit of 815 on sale
2025-04-07 SELL -33 31.530 34.050 33.798 USD -1,115 58.67 Profit of 821 on sale
2025-04-04 SELL -165 32.650 34.240 34.081 USD -5,623 59.19 Profit of 4,144 on sale
2025-04-01 BUY 136 35.870 37.800 37.607 USD 5,115 60.14
2025-03-31 SELL -99 37.870 39.350 39.202 USD -3,881 60.61 Profit of 2,120 on sale
2025-03-21 BUY 1,163 37.120 38.150 38.047 USD 44,249 63.96
2025-03-14 SELL -480 38.280 38.605 38.572 USD -18,515 67.56 Profit of 13,914 on sale
2025-03-07 SELL -60 38.500 39.430 39.337 USD -2,360 72.39 Profit of 1,983 on sale
2025-03-04 SELL -30 36.210 37.630 37.488 USD -1,125 76.14 Profit of 1,160 on sale
2025-02-25 BUY 58 66.890 68.930 68.726 USD 3,986 80.85
2025-02-19 SELL -29 81.080 84.720 84.356 USD -2,446 81.99 Loss of -69 on sale
2025-02-13 BUY 87 86.660 87.630 87.533 USD 7,615 80.73
2025-02-12 BUY 29 85.400 86.280 86.192 USD 2,500 80.39
2025-02-11 BUY 116 84.240 85.090 85.005 USD 9,861 80.10
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	35	174.990	160.375	161.837	USD 5,664	62.07
2025-11-06	BUY	35	175.960	160.900	162.406	USD 5,684	60.64
2025-11-04	BUY	35	186.600	171.740	173.226	USD 6,063	59.21
2025-10-30	BUY	175	206.360	191.390	192.887	USD 33,755	56.46
2025-10-29	BUY	70	195.760	198.290	198.037	USD 13,863	55.51
2025-10-22	SELL	-140	184.430	192.960	192.107	USD -26,895	50.94 Loss of -19,764 on sale
2025-10-20	BUY	70	175.070	190.270	188.750	USD 13,213	49.04
2025-10-17	BUY	175	189.990	203.575	202.216	USD 35,388	48.02
2025-10-15	BUY	280	57.350	57.630	57.602	USD 16,129	47.95
2025-10-03	BUY	245	54.380	55.860	55.712	USD 13,649	47.87
2025-10-02	BUY	35	55.190	55.195	55.194	USD 1,932	47.82
2025-09-30	BUY	70	53.000	55.330	55.097	USD 3,857	47.74
2025-09-26	BUY	70	52.440	53.725	53.596	USD 3,752	47.67
2025-09-25	BUY	70	49.250	50.560	50.429	USD 3,530	47.65
2025-09-18	BUY	35	45.230	47.980	47.705	USD 1,670	47.67
2025-09-17	BUY	105	44.030	46.050	45.848	USD 4,814	47.70
2025-09-11	SELL	-35	39.420	40.690	40.563	USD -1,420	47.81 Profit of 254 on sale
2025-09-10	BUY	70	40.230	40.610	40.572	USD 2,840	47.88
2025-07-17	SELL	-70	54.940	58.340	58.000	USD -4,060	47.77 Loss of -716 on sale
2025-07-11	SELL	-280	50.540	51.380	51.296	USD -14,363	47.61 Loss of -1,032 on sale
2025-07-02	BUY	1,925	46.320	46.600	46.572	USD 89,651	47.58
2025-06-25	BUY	70	43.330	44.100	44.023	USD 3,082	47.74
2025-06-20	BUY	609	42.340	43.270	43.177	USD 26,295	47.89
2025-06-11	BUY	66	44.595	46.930	46.697	USD 3,082	48.18
2025-06-10	BUY	66	45.850	46.090	46.066	USD 3,040	48.20
2025-06-04	SELL	-33	41.370	42.665	42.536	USD -1,404	48.42 Profit of 194 on sale
2025-04-23	BUY	33	36.590	37.970	37.832	USD 1,248	53.49
2025-04-10	SELL	-264	28.470	30.175	30.004	USD -7,921	57.10 Profit of 7,153 on sale
2025-04-08	SELL	-33	28.600	33.990	33.451	USD -1,104	58.15 Profit of 815 on sale
2025-04-07	SELL	-33	31.530	34.050	33.798	USD -1,115	58.67 Profit of 821 on sale
2025-04-04	SELL	-165	32.650	34.240	34.081	USD -5,623	59.19 Profit of 4,144 on sale
2025-04-01	BUY	136	35.870	37.800	37.607	USD 5,115	60.14
2025-03-31	SELL	-99	37.870	39.350	39.202	USD -3,881	60.61 Profit of 2,120 on sale
2025-03-21	BUY	1,163	37.120	38.150	38.047	USD 44,249	63.96
2025-03-14	SELL	-480	38.280	38.605	38.572	USD -18,515	67.56 Profit of 13,914 on sale
2025-03-07	SELL	-60	38.500	39.430	39.337	USD -2,360	72.39 Profit of 1,983 on sale
2025-03-04	SELL	-30	36.210	37.630	37.488	USD -1,125	76.14 Profit of 1,160 on sale
2025-02-25	BUY	58	66.890	68.930	68.726	USD 3,986	80.85
2025-02-19	SELL	-29	81.080	84.720	84.356	USD -2,446	81.99 Loss of -69 on sale
2025-02-13	BUY	87	86.660	87.630	87.533	USD 7,615	80.73
2025-02-12	BUY	29	85.400	86.280	86.192	USD 2,500	80.39
2025-02-11	BUY	116	84.240	85.090	85.005	USD 9,861	80.10

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of PRAX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	47,425	0	67,182	70.6%
2025-09-18	88,273	0	115,157	76.7%
2025-09-17	130,627	11	178,532	73.2%
2025-09-16	69,107	5	116,737	59.2%
2025-09-15	70,710	0	102,443	69.0%
2025-09-12	46,762	0	117,328	39.9%
2025-09-11	46,883	0	83,093	56.4%
2025-09-10	44,317	0	91,289	48.5%
2025-09-09	142,381	1,051	267,521	53.2%
2025-09-08	500,171	3,037	796,055	62.8%
2025-09-05	46,006	0	105,701	43.5%
2025-09-04	34,091	420	53,774	63.4%
2025-09-03	59,820	0	133,993	44.6%
2025-09-02	33,744	0	83,031	40.6%
2025-08-29	35,854	0	112,195	32.0%
2025-08-28	24,421	0	73,401	33.3%
2025-08-27	51,211	0	172,116	29.8%
2025-08-26	36,214	0	64,296	56.3%
2025-08-25	43,209	0	61,805	69.9%
2025-08-22	42,502	0	110,466	38.5%
2025-08-21	25,300	0	49,879	50.7%
2025-08-20	38,695	0	101,807	38.0%
2025-08-19	74,497	0	132,622	56.2%
2025-08-18	95,795	0	573,243	16.7%
2025-08-15	45,573	0	81,941	55.6%
2025-08-14	44,898	0	79,375	56.6%
2025-08-13	34,854	0	192,111	18.1%
2025-08-12	81,597	0	218,064	37.4%
2025-08-11	120,841	0	374,071	32.3%
2025-08-08	111,139	0	183,059	60.7%
2025-08-07	49,684	0	76,030	65.3%
2025-08-06	106,544	0	181,870	58.6%
2025-08-05	180,765	2,134	289,065	62.5%
2025-08-04	298,659	5,949	564,912	52.9%
2025-08-01	85,034	0	249,944	34.0%
2025-07-31	66,326	15	184,793	35.9%
2025-07-30	83,251	0	212,476	39.2%
2025-07-29	79,724	40	183,744	43.4%
2025-07-28	81,762	9	148,827	54.9%
2025-07-25	107,388	77	190,856	56.3%
2025-07-24	87,402	423	176,984	49.4%
2025-07-23	84,760	0	208,647	40.6%
2025-07-22	124,413	0	184,692	67.4%
2025-07-21	92,015	80	200,249	46.0%
2025-07-18	56,726	254	187,172	30.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE